Stockscreener 앱 받기
5.62
0.35%
-0.02
전일 마감가:
$5.64
열려 있는:
$5.61
하루 거래량:
98,798
Relative Volume:
1.54
시가총액:
$37.87M
수익:
$21.23M
순이익/손실:
$-72.42M
주가수익비율:
-0.8298
EPS:
-6.7728
순현금흐름:
$-81.69M
1주 성능:
+2.55%
1개월 성능:
+4.46%
6개월 성능:
-0.53%
1년 성능:
-40.61%
1일 변동 폭
$5.60
$5.66
1주일 범위
$5.54
$5.70
52주 변동 폭
$3.004
$10.40
제너레이션 바이오 Stock (GBIO) Company Profile
명칭
Generation Bio Co
전화
857-529-5908
주소
301 BINNEY STREET, CAMBRIDGE
GBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
5.62 | 38.01M | 21.23M | -72.42M | -81.69M | -6.7728 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
제너레이션 바이오 Stock (GBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-12-16 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2025-08-13 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-10-19 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | 개시 | Canaccord Genuity | Buy |
| 2021-12-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | 개시 | JMP Securities | Mkt Outperform |
| 2021-02-24 | 개시 | William Blair | Outperform |
| 2021-02-18 | 개시 | Needham | Buy |
| 2020-07-07 | 개시 | Cowen | Outperform |
| 2020-07-07 | 개시 | JP Morgan | Overweight |
| 2020-07-07 | 개시 | Jefferies | Buy |
| 2020-07-07 | 개시 | Wedbush | Outperform |
모두보기
제너레이션 바이오 주식(GBIO)의 최신 뉴스
Aug Levels: Can Generation Bio Co grow without external fundingWeekly Trend Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
Aug PostEarnings: Will Generation Bio Co outperform small cap indexesTrade Entry Summary & Daily Stock Trend Reports - baoquankhu1.vn
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—FFWM, CFLT, GBIO, and CTGO - GlobeNewswire Inc.
Generation Bio Co. (NASDAQ:GBIO) Receives Average Rating of “Hold” from Analysts - Defense World
Can Generation Bio Co. stock sustain institutional interestBear Alert & Free Community Consensus Stock Picks - Улправда
Can Generation Bio Co. stock sustain revenue growthJuly 2025 Update & Growth Focused Entry Reports - Улправда
Can Generation Bio Co. stock weather global recessionJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - ulpravda.ru
Generation Bio (NASDAQ:GBIO) Stock Price Down 0.4% – Here’s What Happened - Defense World
What analysts say about Generation Bio Co stockMarket Sentiment Extremes & These Picks Are Just One Breakout Away - earlytimes.in
Generation Bio (GBIO) price target decreased by 70.88% to 9.01 - MSN
Jefferies downgrades Generation Bio (GBIO) - MSN
Generation Bio trading halted, news pending - MSN
Patterns Watch: Can Generation Bio Co stock sustain revenue growthTrade Analysis Report & Weekly Stock Performance Updates - moha.gov.vn
How Generation Bio Co. stock reacts to global recession fearsTrade Analysis Summary & Daily Entry Point Trade Alerts - Улправда
Brokerages Set Generation Bio Co. (NASDAQ:GBIO) PT at $9.25 - Defense World
Why Generation Bio Co. stock remains on buy listsEarnings Trend Report & Real-Time Volume Triggers - DonanımHaber
Why Generation Bio Co. stock is rated strong buyDividend Hike & Target Return Focused Picks - Улправда
Is Generation Bio Co. stock a safe buy before earningsJuly 2025 Chart Watch & Fast Gaining Stock Reports - Улправда
Retail Trends: Why Generation Bio Co. stock is rated strong buyJuly 2025 Volume & Long Hold Capital Preservation Tips - Улправда
Generation Bio stock rating reiterated at Market Perform by Citizens - Investing.com South Africa
Generation Bio trading resumes - MSN
Generation Bio announces merger with XOMA Royalty - MSN
Generation Bio stock rating reiterated at Market Perform by Citizens By Investing.com - Investing.com Canada
Generation Bio (NASDAQ:GBIO) Given a $5.50 Price Target at Wedbush - Defense World
Wedbush Upgrades Generation Bio (GBIO) - Nasdaq
Generation Bio (GBIO) Price Target Increased by 13.40% to 30.94 - MSN
Generation Bio (GBIO) Rating Update: Wedbush Upgrades to Outperf - GuruFocus
NodThera appoints Geoff McDonough, M.D., as independent board member - marketscreener.com
GBIO Downgraded by Jefferies with Price Target Cut by 54.55% | G - GuruFocus
‘Zombie’ biotech buyer Xoma to acquire Generation Bio - BioPharma Dive
Wedbush Upgrades Generation Bio to Outperform From Neutral, Adjusts Price Target to $5.50 From $7 - marketscreener.com
Jefferies Downgrades Generation Bio to Hold From Buy, Adjusts Price Target to $5 From $11 - marketscreener.com
Hold Rating on XOMA’s Acquisition of Generation Bio: Balancing Immediate Cash Offer with Potential Future Returns - TipRanks
Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced - Investing.com Nigeria
XOMA Strikes Deal To Acquire Generation Bio, Expanding Royalty Portfolio - Nasdaq
XOMA to Acquire Generation Bio (GBIO) in Strategic Merger - GuruFocus
XOMA royalty to acquire Generation Bio - MSN
XOMA Royalty to Acquire Generation Bio - citybiz
The Ademi Firm Investigates Whether Generation Bio Co. Is Obtaining a Fair Price for Its Public Shareholders - 富途牛牛
GBIO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Generation Bio Co. is Fair to Shareholders - The AI Journal
Generation Bio Announces Merger with XOMA Royalty - TipRanks
Xoma Royalty enters into agreement to acquire Generation Bio - marketscreener.com
Xoma to acquire Generation Bio for $4.2913 per share - TipRanks
XOMA Royalty Corporation to Acquire Generation Bio Co. in Cash Transaction with Milestone and Royalty Opportunities - Quiver Quantitative
Generation Bio (NASDAQ: GBIO) agrees to XOMA cash plus CVR takeover - Stock Titan
XOMA Royalty Enters into Agreement to Acquire Generation Bio - GlobeNewswire
Xoma to Acquire Generation Bio (GBIO) for $4.29 Per Share - GuruFocus
XOMA Royalty Corporation entered into an agreement to acquire Generation Bio Co. for $28.92 million. - marketscreener.com
Published on: 2025-12-14 17:13:04 - moha.gov.vn
Is Generation Bio Co. stock gaining market share2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
제너레이션 바이오 (GBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):